TRIAMINIC NIGHT TIME COLD & COUGH OTC
Generic Name and Formulations:
Diphenhydramine HCl 6.25mg, phenylephrine HCl 2.5mg; per 5mL; liq; alcohol-free; grape-flavored; contains sodium 6mg/5mL.
Novartis Consumer Health
Indications for TRIAMINIC NIGHT TIME COLD & COUGH:
Rhinorrhea, congestion, cough, allergy symptoms.
<4yrs: do not use. 4–6yrs: individualize. 6–12yrs: 10mL, repeat every 4hrs as needed; max 6 doses/24hrs.
Children <4yrs old. During or within 14 days of MAOIs. Concomitant diphenhydramine products (including topicals). For use as a sedative hypnotic.
Hypertension. Cardiovascular disease. Thyroid disease. Diabetes. Glaucoma. Asthma. Lower respiratory disorders. Discontinue if symptoms worsen or persist for ≥7 days.
Antihistamine + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, dizziness, nervousness, insomnia, excitability in children.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Lithium Monotherapy Effective in Treating Bipolar Disorder in Children
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Computerized Training Programs for Schizophrenia Improve Cognitive Functioning
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Cost-Effective Telehealth Alternatives for Veterans With Depression
- Polygenic Risk Scores Could Aid in Identifying Bipolar Disorder, Schizophrenia
- Brief Impression Questionnaire Useful in Schizophrenia Diagnoses